NNVC NanoViricides Inc

$NNVC Added a bunch of March $2.50 calls this morning at $0.16 and they're up 20% already. This stock is so undervalued that any positive news from the Ebola trial will send it up at least 5x from the current price. This is a high risk play, as nothing so far has been able to show any success with Ebola, but the reward side is a clear 100x gain if they are successful in this trial.

$NNVC Part 1 Having been invested in this company for over 12 years, travelled to the lab on numerous occasions for investor meetings and lab tours, as well as having attended 2 Annual Meetings (2016 and 2018), I am uniquely qualified to state the following: I defy any of you reading this blog to show me a more undervalued stock in today's market. Most of you "lerkers" are convinced that this company, with a market value of only $33 million, CAN'T POSSIBLY HAVE a cure for over 90% of all viruses, past, present, and future, as has been stated ad nauseum by Love1010, the mouthpiece for a group of hedge funds, who frontrun every trade and illegally short **all buy orders in an attempt to make raising capital so dilutive that Anil would sell the company "for peanuts" compared to what he will soon command. Don't believe a word of it !!! ** The short interest report announced Friday after the close was that the "Cabal" was now ILLEGALLY short 925,460 shares, 3.72% of the shares outstanding.

$NNVC Part 2 Against all odds, NNVC (Dr. Anil Diwan) has persevered and now stands only WEEKS AWAY from announcing that NV-387, his therapeutic drug for ALL viruses, has SAVED EVERY LIFE AFTER ONLY 12 DAYS of 1 Gummy each morning (2 - 6 packs of Oral Gummies) from the deadliest-known Ebola strain, (Bindibugyo), where an untreated patient has an 80% fatality rate. When successful, there is tremendous potential --- Strategic National Stockpile (SNS) markets in the $200-$500 million per year, US Government support for expanding the manufacturing facility, as well as taking NV-387 through US FDA regulatory approval process. ALL BECOME A REALITY !!!

$NNVC It has now been a little over 4 weeks since patients began treatment with 387. I would imagine that if cures were ensuing that word would start to get out. If I were cured of a fatal disease I would be telling my relatives, friends, coworkers who would be telling their...You get the point. If efficacy is robust, glimpses will emerge in the public sphere even without formal PR. By Thanksgiving/Christmas we may have a lot to be thankful for. Just my thoughts.

$NNVC Starting to get some attention. I received this NYSE alert in my email this morning:

$NNVC: Be advised that there is a regulatory requirement that Nano cannot release any information about the Phase 2A Ebola efficacy trial (in Ituri Province, DRC) until it has completed the 20 patient enrollment and then 28 days have elapsed with the last patient post-admission. Dr. Diwan (Anil) is hopeful that the benefits of even 3 days of Oral Gummies melting on a patient's tongue, with the release of billions of nanoviricdes in the bloodstream each of those mornings, enveloping the virus particles and killing them, will show such improvement in each patient' health that enrollment will be speeded up and the 28 day wait-time for the last of the 20 being dosed will be dramatically shortened. Let's hope so!

$NNVC any good, successful company is like anything else…moderna pfizer etc. $NNVC will prove itself and climb and climb and climb, maybe get bought out. Bears will be bears just like moderna pfizer etc have their days. Not every day is green. But soon it will be too late, and everyone will be forced to buy this. Buy what you believe in. Simple. That’s how you succeed in this market

$NNVC - One article I read about this suggests it was 'pneumoic plague' If so - that's caused by a bacterial pathogen named Yersinia pestis. NV-387 would not be effective against that - just standard antibiotics.

$NNVC If 387 were to show efficacy during this Ebola outbreak, it would be at a time of worldwide heightened awareness. I came across a Fox News article, "Deadly disease sparks new CDC rule for US bound flyers as major airlines seek delay." It is creepily reminiscent of the COVID mandate in 2020.

$NNVC ... how much back door news do you expect out of DRC? Expect none for now...trials are reported growing out of precaution announced. When NNVC hits... look for 10X ($14.00) for starters... 20X when rest of market wake's up re: Barda demand for immediate ramp-up of production

$NNVC if they can make gummies they can do sublingual under the tongue ,I'm sure. For those that can't swallow a gummy.

$NNVC Ebola is an excellent study population with the IFR running 65-75% to show efficacy of 387 than say measles with an IFR of only 0.2%. That is because the events(deaths) are so much more frequent and rapid in Ebola vs measles that it takes a smaller study population and a shorter time frame. The only downside could be the exclusion of patients with vomiting in Ebola who are unable to keep down the gummies. Question: Is there also a parenteral route for 387? Just wondering. The IV route might be useful in certain situations. It is common in infectious disease to start with an IV antibacterial and then switch to an oral one once the patient has improved somewhat.

$NNVC Nanoviricides presenting at niba's 153rd investment conference in fort lauderdale, fl october 7, 2026

$NNVC From the Forbes article (ref ii in the latest PR), the best strategy to combat and stop Ebola BDBV, is to administer NNVC's NV-387,oral gummies, to anyone with Ebola symptoms or testing positive and all their contacts. The ring vaccination approach only helps the outer most part of the population centered around the BDBV epicenter. Vaccines do nothing for people already infected. On average, for each person infected with BDBV, they spread it to 2-3 others.

$NNVC presents Phase IIA Ebola oral gummy trial progress, eyeing Phase IIB start after completion.

$NNVC - Things are decidedly looking up of late. I would be excellent to see this company's stock claw it's way back above the 52 week high at some point during the next few weeks.

$NNVC yup I’ve got some 2 fiddyies. Am taking a gander at a few speculative Ebola stocks. Everything else is getting killed and bio catches bids then. Bola is back in the news and might get some motion in next few weeks.

$NNVC What probability is there that they will do a offering, now that they are up? It looks like they are low on cash.

$NNVC the penny suckers come out when it goes up to pennies they sell and go put gas in their car go play somewhere else 

$NNVC +13.0% intraday (11:09 ET) — Oct 20: NanoViricides reported that NV-387 showed favorable safety and toxicology indications in a juvenile mouse pup study, which the company says supports pediatric use in clinical trials (company press release). Daily chart: 1.47 USD, above the 50-day SMA (1.31 USD) and the 200-day SMA (1.28 USD) after a range between 1.25 and 1.45 USD in recent weeks. The descending trendline from the May and July highs sits near 1.63 USD. Not investment advice.